Find Academic Supervisors

• Computational Biology
• Plant Genetics
• Bioinformatics
• +3 more

Felix Leopold Sandell is a researcher at the Institute of Computational Biology within the Department of Biotechnology and Food Science at the University of Natural Resources and Life Sciences, Vienna (BOKU). His work focuses on computational approaches to plant genomics, particularly in Amaranthaceae crops like beet and quinoa. He has contributed to phylogenetic studies of Beta vulgaris and developed methods for genomic variant analysis. Active in Systems Biology research for monoclonal antibody production in CHO cells Key contributor to Genomic distances analysis in wild and cultivated beets Expertise in K-mer phylogeny and Haplotype block detection Research Focus Dr. Sandell's publications reveal specialization in computational phylogenetics , plant genomic diversity , and bioinformatics methodologies . His work spans from fundamental studies in plant evolution to applied research in biopharmaceutical production . Recent articles in Proteomes and Plant Biotechnology Journal demonstrate his dual expertise in proteomics and agricultural genomics . He has presented at major conferences including ISMB/ECCB and INTERPRAEVENT, focusing on genomic analysis of crop traits .

• Bioprocess Engineering
• Gene Therapy Vectors
• Protein Production
• +4 more

Astrid Dürauer is a Privatdozent (Associate Professor) at the Institute of Bioprocess Science and Engineering within the University of Natural Resources and Life Sciences, Vienna (BOKU) . She holds leadership roles including Head of the Christian Doppler Laboratory for Knowledge-based Production of Gene Therapy Vectors and Deputy Head of the Department of Biotechnology . Her career spans over two decades in bioprocess development, with a focus on downstream processing, protein purification, and data-driven process modeling. PhD in Biotechnology (2001, BOKU Vienna) Habilitation in Bioprocess Engineering (2019, BOKU Vienna) Astrid's research centers on bioprocess optimization , particularly for gene therapy vectors and recombinant proteins . She pioneers the integration of machine learning and statistical models to enhance real-time monitoring and predictive analytics in downstream operations. Key projects include automation of process development, membrane fouling mitigation, and scalable chromatography systems. Her 15 most recent publications (2022–2025) highlight trends in explainable AI for biopharmaceutical processes, AAV vector production , HEK293 cell characterization , and continuous downstream processing . These works bridge biotechnology , data science , and industrial scalability . Scientific recognition includes: Head of Christian Doppler Laboratory (2023) Habilitation in Bioprocess Engineering (2019) She has led 7 funded projects (2014–2029) and served as Deputy Scientific Head for the BOKU Core Facility Biomolecular & Cellular Analysis (2020). Her work involves collaborations across statistics , molecular biotechnology , and industrial partners .

Gomika UdugamasooriyaView profile

Professor

• Peptoids and Peptidomimetics
• Cancer Diagnostics
• Cancer Therapeutics
• +5 more

Gomika Udugamasooriya is a Professor in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy , with adjunct appointments at The University of Texas MD Anderson Cancer Center (Department of Cancer Systems Imaging) and Baylor College of Medicine (Dan L. Duncan Comprehensive Cancer Center). Her research focuses on peptoid and peptidomimetic development for cancer diagnostics, therapeutics, and theranostic tools. Education : PhD in Bioorganic Chemistry from Wayne State University, BSc in Chemistry from University of Colombo Her work spans cancer stem cell biomarker identification , high-throughput cell screening , and antiviral drug design (e.g., ACE2-targeting SARS-CoV-2 inhibitors). Recent publications emphasize vimentin-binding peptoids for lung cancer targeting and ERK5 kinase inhibitors to suppress cancer stem cell activity. Scientific awards include NIH SPORE Career Development Award and 50-in-5 Scholar recognition from the University of Houston.

• Hepatitis C Virus Research
• Liver Disease
• Molecular Biology
• +4 more

Professor Debra Bevitt is a faculty member at Newcastle University specializing in virology, hepatology, and molecular biosciences. Her research integrates laboratory investigation with clinical applications, particularly in hepatitis C virus pathogenesis and liver disease mechanisms. She maintains active collaborations across medical and biological disciplines within the university. Her primary research interests focus on hepatitis C virus antigen expression, viral density heterogeneity in immunocompromised hosts, and molecular mechanisms of hepatic fibrogenesis involving ADAMTS metalloproteinases and TIMP3. Significant contributions include elucidating TNFα-mediated regulation of metalloproteinases in retinal cells and characterizing viral structural proteins in infected liver tissue. Later work expanded into biosciences education methodology, developing early intervention systems for student performance monitoring. Publication trends from 1996-2020 reveal strong continuity in virology research with progressive diversification into educational scholarship. Core themes include viral pathogenesis (40% of publications), molecular mechanisms of fibrosis (30%), and biosciences pedagogy (20%), demonstrating adaptability while maintaining focus on liver disease pathophysiology. Her work consistently bridges basic science and clinical applications, particularly in transplantation immunology and retinal degeneration disorders.

Martí Lecina VecianaView profile

Professor

• Bioprocessing
• Cell Culture
• Bioreactor Design
• +6 more

Martí Lecina Veciana is a Full Professor in the Department of Bioengineering at IQS School of Engineering, Universitat Ramon Llull, where he leads research in bioprocessing and cell culture technologies. His academic journey includes a Chemical Engineering degree (UAB, 2000), Master in Biotechnology (UAB, 2002), PhD in Biotechnology (UAB, 2007), and post-doctoral work in stem cell biology and bioprocess engineering. His research focuses on bioprocess development and optimization , specializing in cell culture systems for human embryonic stem cells (hESC), induced pluripotent stem cells (iPSC), microalgae, and plant cells. Dr. Lecina Veciana's work spans recombinant protein production, monoclonal antibodies, vaccine candidates, and the design of bioreactors with single-use elements. His research group, GEMAT (Materials Engineering Group), operates at the intersection of materials science and biotechnology. Analysis of his recent publications reveals strong emphasis on extracellular vesicles , high cell density culture strategies , and plant cell biotechnology for cosmetic applications . His work demonstrates expertise in metabolic flux analysis, bioreactor monitoring systems, and nanoscale characterization of cell culture processes. Principal Investigator for CERTERA consortium (State network for advanced therapy drugs) Lead researcher for VEG4COS project (sustainable cosmetics from plant stem cells) Coordinator of LUNGEVs project (extracellular vesicles for lung cancer treatment) Member of GEMAT research group focusing on biomaterials development Dr. Lecina Veciana actively collaborates with industry partners like Provital on industrial doctorates focused on cosmetic applications of plant cell technology. His work bridges fundamental research with commercial applications in biopharmaceuticals and cosmetics, demonstrating strong translational impact.

• Plant-Based Bioproduction
• Genetic Engineering
• Genome Editing
• +7 more

Jianfeng (Jay) Xu is a Professor of Biochemical Engineering at Arkansas State University's Beck College of Sciences & Mathematics, Department of Molecular Biosciences. He holds a Ph.D. in Biochemical Engineering from Dalian University of Technology, China (2001) and a B.S. in Environmental Engineering from the same institution (1998). Research focuses on plant-based bioproduction platforms using genetic engineering and genome editing Developed "HypGP Engineering" technology for 500-fold protein yield increases Applications in biopharmaceuticals for IBD treatment and biofuels from switchgrass Active research grants from NIH, NSF, USDA, and DOE Patents (8 total) include methods for plant glycoprotein production and biomass enhancement. Google Scholar publications (selected) demonstrate expertise in plant cell engineering, glycosylation technologies, and biopharmaceutical development. Current work explores CRISPR/Cas9 applications in tobacco BY-2 cells and plant cell wall engineering for improved biomass processing. His research spans two major domains: plant-based biopharmaceutical production (therapeutic proteins, growth factors, oral medications) and plant cell wall engineering for enhanced biofuel production. Recent publications emphasize optimizing plant expression systems through glycomodules and improving biomass digestibility via cell wall modifications. Key collaborations include work with colleagues at Arkansas Biosciences Institute , where he maintains laboratory space. Current research directions focus on commercializing plant cell culture platforms and developing designer biologics for medical applications.

• Arbovirology
• Mosquito Biology
• Vector-virus Interactions
• +7 more

Claudia Rückert is an Assistant Professor in the Department of Biochemistry & Molecular Biology at the University of Nevada, Reno . She directs the Rückert Lab , where her team investigates virus-vector interactions to curb arbovirus transmission. Education Ph.D., University of Edinburgh, UK, 2014 M.S., University of Heidelberg, Germany, 2010 B.S., University of Heidelberg, Germany, 2008 Research Focus Her research spans arbovirology, vector biology, and mosquito antiviral immunity . Key goals include: Decoding mosquito immune responses to flaviviruses and alphaviruses. Engineering genetic tools such as CRISPR/Cas9 knock-in Culex quinquefasciatus cells. Exploiting small RNA pathways and pattern-recognition receptors like Toll6 to block viral replication. Developing field-applicable transmission-control strategies using endectocide-treated blood meals. Current projects extend to tick-borne virus evolution, microRNA profiling in vectors, and xenosurveillance in rural Guatemala . Teaching Contributions BCH 405/605 – Molecular Biology (Spring) BCH 790 – Biochemistry Seminar (Spring & Fall) Publications Snapshot Since 2016, Dr. Rückert has authored >30 peer-reviewed papers. Her work charts viral population dynamics, immune evasion, and gene-editing breakthroughs across Aedes , Culex , and tick systems, consistently bridging molecular mechanisms with epidemiological impact. Laboratory & Team The Rückert Lab—based in the Howard Medical Sciences (HMS) Building, Room 157B—integrates cell culture, high-throughput sequencing, and mosquito infection models to accelerate translational vector-borne disease research.

• Epidemiology
• Public Health
• Cancer Research
• +3 more

Dr. Peter James is a researcher at Newcastle University specializing in epidemiology and public health with a focus on cancer incidence , survival analysis , and socioeconomic health disparities . His work spans pediatric oncology , environmental risk factors , and chronic liver disease epidemiology. Key collaborations with Dr. Richard McNally and Professor Mark Pearce Active in geospatial health research and population-based disease modeling His research includes clinical diagnosis frameworks for neurodegenerative diseases, stem cell models for neuroblastoma pathogenesis, and statistical analyses of thyroid cancer trends post-nuclear exposure. Publications demonstrate expertise in longitudinal studies and environmental health correlations . Recent work examines digital health interventions for cerebral palsy rehabilitation and socioeconomic deprivation impacts on cancer outcomes. While no explicit awards are documented, his 15+ years of publications reveal consistent contributions to health policy and clinical epidemiology .

Yimin ZhuView profile

Associate Professor

• Plant Cell Wall Biology
• Lignin Chemistry
• Chemical Synthesis
• +3 more

Yimin Zhu is an Associate Professor at Penn State University, affiliated with the Division of Mathematics & Natural Sciences at Penn State Altoona. His research intersects plant cell wall biology , lignin chemistry , and materials science , focusing on monolignol synthesis, lignification mechanisms, and topological materials. University: Penn State University Title: Associate Professor Email: yuz30@psu.edu Dr. Zhu’s publications highlight interdisciplinary work, including synthesis of monolignols , lignin engineering in maize , and studies on nodal-line semimetals and superconductivity in Heusler compounds . His research keywords span Biochemistry , Materials Science , and Chemical Synthesis , with sub-fields covering lignification, quantum materials, and phenolic compound engineering. He was awarded the Schreyer Institute Teaching Grant in 2022-23 and received IEE seed grants for interdisciplinary projects.

• Materials Science
• Bioengineering
• Biomaterials
• +4 more

Piedad Nieves is a Professor at the Universidad Miguel Hernández (UMH), affiliated with the Institute of Bioengineering and the Department of Materials Science, Optics and Electronic Technology. She coordinates courses in Biotechnology and Fashion Management and Technology at both bachelor's and master's levels, focusing on biomaterials, material technology, and biotechnological applications. Her research centers on the development and characterization of ceramic scaffolds for bone tissue engineering, with a particular emphasis on bioactive materials, ion doping, and surface modifications to enhance regenerative outcomes. As Director of the Research Group in Materials Science and a member of the University Senate (Sector 1), she oversees the Characterization of Solid Materials laboratory. Her work includes preclinical testing of dental implants, biomechanical analysis of implant macrogeometries, and in vitro/in vivo studies of stem cell responses to ceramic substrates. She maintains an active teaching schedule across multiple academic years, with laboratory and lecture responsibilities in courses such as Biotechnological Material and Research Activities and Funding. Contact details include her office at Edificio Torrevaillo, Avda. Universidad s/n, 03202 Elche, Spain, and phone numbers +34 96 665 8485 (direct) or +34 96 522 2000 (institute line). Her research outputs span 3D porous scaffolds, titanium surface treatments, and novel implant designs with mechanical and biological evaluations.

• Drug Discovery
• Immunology
• Signal Transduction
• +3 more

Prof. Dr. Belkıs Atasever Arslan is a Professor in the Department of Molecular Biology and Genetics at Üsküdar University , where she has served since 2012. She holds an Adjunct Associate Professor position at the University of Illinois at Chicago (since 2019) and leads the Molecular Biotechnology Research Group . With a Doctorate in Physiology (Istanbul University, 2008), her career includes postdoctoral work at Sabancı University (2009-2012) and leadership roles as Department Head since 2019. 2001: B.Sc. in Biology, Istanbul University 2004: M.Sc. in Physiology, Istanbul Faculty of Medicine 2008: Ph.D. in Physiology, Istanbul Faculty of Medicine Research Interests span Drug Discovery , Immunology , and Signal Transduction , with a focus on neurodegenerative diseases (Alzheimer's, Parkinson's), cancer biology (leukemia, endometrial cancer), and metal toxicity. Her work integrates in vitro models , computational biology , and metal-based therapeutics . Recent Publications (2025-2020) emphasize metal complexes for antiviral/anticancer applications, neuroprotective natural compounds (sesamol, Hypericum), and genetic biomarkers in neurodegeneration. Key journals include Journal of Molecular Structure , Toxicology Reports , and Pharmacognosy Magazine . Scientific Awards include the TÜBA Postdoctoral Fellowship (2009), TÜBİTAK Scholarships , and European Patents . She has supervised 5+ graduate theses and participates in international conferences (e.g., Artemis Scientific Research Congress, ICSTR Rome). Administrative Roles include Department Head (2019-present), Academic Committee Membership , and leadership in Erasmus Coordinations . She teaches Physiology , Signal Transduction , and Immunology courses.

• Pharmacoepidemiology
• Clinical Pharmacology
• Oncology
• +5 more

Dr. Ewoudt van de Garde is an Associate Professor of Clinical Pharmacotherapy at the Division of Pharmacoepidemiology and Clinical Pharmacology, Faculty of Science, Utrecht University. He also serves as a Hospital Pharmacist at St. Antonius Hospital in Utrecht/Nieuwegein and is board certified as both a Clinical Pharmacologist and Epidemiologist. His academic career spans over 15 years with significant contributions to pharmacoepidemiology and clinical pharmacology. Dr. van de Garde completed his pharmacy degree in 2002 and began his training as a hospital pharmacist at St. Antonius Hospital in 2003 while conducting doctoral research on lower respiratory tract infections. He earned his doctorate in 2007, obtained his epidemiology certification in 2008, and became a medical staff member at St. Antonius Hospital that same year. Since 2012, he has maintained a part-time academic position at Utrecht University while continuing his hospital work. In 2016, he obtained his clinical pharmacology designation and became a hospital pharmacy trainer. Dr. van de Garde's primary research focus is on understanding how pre-marketing authorization clinical trial results translate to real-world outcomes. He conducts efficacy-effectiveness studies primarily in the fields of oncology and inflammatory diseases . His current work also explores applying real-world outcomes data in shared decision making with patients and developing machine learning techniques to shorten the time to appropriate efficacy-effectiveness assessment. Previously, he established and conducted numerous studies to improve clinical outcomes in patients with community-acquired pneumonia. His recent publications reveal a strong focus on comparative effectiveness research across multiple disease areas. In oncology, he examines immunotherapy effectiveness in non-small cell lung cancer and treatment outcomes in bladder cancer. In infectious diseases, his work centers on community-acquired pneumonia management and antibiotic utilization. His methodological contributions include developing text mining algorithms for real-world data analysis and evaluating clinical decision support systems. Member, Scientific Advisory Board of Dutch Healthcare Institute (ZiN) Member, Scientific Advisory Board of Lung Foundation Netherlands (Longfonds) Member, Study Program Committee of School of Pharmacy (UU) Member, several task forces of Netherlands Society of Hospital Pharmacy (NVZA) Dr. van de Garde actively contributes to pharmacotherapy education within the Master's program in Pharmacy. He serves as chair of the Clinical Pharmacy course, is a member of the Program Committee of the School of Pharmacy, and conducts research on the selection process for the pharmacy program. He has supervised over 50 theses and co-supervised 8 PhD students. His research has been supported by grants including a ZonMw grant to investigate the feasibility of an infrastructure for research into real-world clinical effectiveness of pharmacotherapy, which led to the Santeon Pharmadatabase. His research group collaborates across multiple institutions through the Santeon network, which combines data from seven large teaching hospitals in the Netherlands. This infrastructure enables large-scale real-world evidence studies across various therapeutic areas.

Anna ForsbyView profile

Associate Professor

• Neurotoxicity
• Developmental Neurotoxicity
• Neuronal Cell Models
• +3 more

Anna Forsby is an Associate Professor at Stockholm University's Department of Biochemistry and Biophysics, specializing in chemically induced neurotoxicity using neuronal cell models . Her research integrates in vitro data from SH-SY5Y and C17.2 cell lines with in vivo rat studies and human clinical observations to develop predictive risk assessment models. Primary Research Areas: Developmental neurotoxicity, TRPV1 channel function, mitochondrial toxicant detection Key Projects: EU-ToxRisk, ACuteTox, NociOcular test development Her laboratory investigates neuronal differentiation disruptions via signaling pathways like CREB and retinoic acid receptor activation, while developing alternative toxicity assays that align with Adverse Outcome Pathways (AOP) and Integrated Approaches to Testing and Assessment (IATA) . Current students include PhD candidate Ylva Johansson . Publications demonstrate expertise in cellular response mechanisms to neurotoxicants such as acrylamide , neonicotinoid pesticides , and mitochondrial inhibitors , with particular focus on calcium signaling , membrane potential changes , and neurite outgrowth inhibition . Collaborations include Karolinska Institutet for respiratory tract irritation studies.

• Uveal Melanoma
• Ocular Oncology
• Molecular Genetics
• +3 more

Josephine Nguyen is a Researcher in the Department of Ophthalmology at Erasmus University Medical Center Rotterdam, specializing in uveal melanoma molecular genetics. Her work focuses on spliceosome mutations, transcription factors, and genomic biomarkers in ocular oncology. Her primary research areas include Uveal Melanoma , Molecular Genetics of Ocular Tumors , and Transcriptional Regulation in Melanocyte Development . Nguyen investigates how SF3B1 and BAP1 mutations drive tumor progression, with emphasis on chromosome 8q abnormalities and FOXD1 transcription factor roles. Her work integrates genomic profiling with clinical outcomes to identify metastatic risk predictors. Analysis of her publications reveals consistent focus on molecular mechanisms of uveal melanoma progression. Key trends include spliceosome inhibition therapeutics, metastasis prediction models based on mutational profiles, and developmental biology links to high-risk tumors. Her research bridges basic molecular mechanisms with clinical prognostic applications. Nguyen actively collaborates with the Rotterdam Ocular Melanoma Study Group (ROMS), contributing to multi-institutional research on ocular oncology. Her work demonstrates strong translational potential for improving risk stratification and targeted therapies in uveal melanoma.

• Organic Chemistry
• Natural Products Chemistry
• Green Chemistry
• +5 more

Maria Adília Januário Charmier serves as Associate Professor at Lusofona University's Faculty of Engineering in Lisbon, Portugal, while directing the Biotechnology bachelor program and co-leading the Circular Bioeconomy and Technology bachelor program. With over 30 years of teaching experience in General Chemistry, Organic Chemistry, and Natural Products Chemistry through Ciência Viva and Casa da Ciência initiatives, she bridges academic instruction with practical science outreach and campus sustainability as a member of the Faculty's Eco-Schools Council. Her academic credentials include: PhD in Organic Chemistry, Université Blaise Pascal, France (1993) DEA (Diplôme d'études approfondies) in Chemistry, Université Blaise Pascal Maîtrise-ès-Sciences in Chemistry, Université Blaise Pascal Dr. Charmier's research integrates green chemistry principles with biotechnology to develop sustainable solutions. Her primary focus involves microwave-assisted extraction of bioactive compounds from medicinal plants and organic waste streams, and synthesis of metal-coordinated natural product derivatives for pharmaceutical, nutraceutical, and biomaterial applications. This work advances circular bioeconomy models by transforming agricultural and industrial waste into value-added products while minimizing environmental impact. Analysis of her publication history reveals three dominant research trajectories: circular economy applications (particularly waste valorization in food systems), nanotechnology-driven drug delivery systems, and bioinorganic therapeutic development. Recent publications demonstrate increasing interdisciplinary convergence, with 2022-2025 works showing strong integration of sustainability metrics, advanced material characterization, and translational biomedical applications – reflecting evolving priorities in green chemistry and sustainable development. Scientific Awards: No specific awards documented in source materials. Dr. Charmier has supervised multiple Master's and PhD candidates alongside international postdoctoral researchers. Her research funding portfolio includes: International: ERASMUS KA2-STEM Education projects National: FCT grants, P2020 and P2030 innovation programs She maintains dual research affiliations with the Centre of Structural Chemistry (CQE) at IST-UL and Lusofona University's Bioengineering and Sustainability research group (BioRG), where she leads projects on green extraction technologies and metal-based biomaterials. Her industry engagement extends to scientific advisory roles at Cerebio (France) and EXMceuticals Inc. (Canada), including co-founding EXMceuticals Portugal Lda where she served as CEO until 2019.